VIDEO: CorneaGen to use $37 million financing to advance Corneal Cell Therapy

ByMonty Montoya

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting, Monty Montoya, CEO of CorneaGen, discusses the company’s plans to use the recently announced Series B round of financing to develop Cornea Cell Therapy for treatment of endothelial diseases.